574 related articles for article (PubMed ID: 27826630)
1. Infliximab quantitation in human plasma by liquid chromatography-tandem mass spectrometry: towards a standardization of the methods?
Jourdil JF; Lebert D; Gautier-Veyret E; Lemaitre F; Bonaz B; Picard G; Tonini J; Stanke-Labesque F
Anal Bioanal Chem; 2017 Feb; 409(5):1195-1205. PubMed ID: 27826630
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous Quantification of Adalimumab and Infliximab in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
Jourdil JF; Némoz B; Gautier-Veyret E; Romero C; Stanke-Labesque F
Ther Drug Monit; 2018 Aug; 40(4):417-424. PubMed ID: 29608486
[TBL] [Abstract][Full Text] [Related]
3. Quantification of active infliximab in human serum with liquid chromatography-tandem mass spectrometry using a tumor necrosis factor alpha -based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: A target-based, sensitive and cost-effective method.
El Amrani M; van den Broek MP; Göbel C; van Maarseveen EM
J Chromatogr A; 2016 Jul; 1454():42-8. PubMed ID: 27264745
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Quantification of Free Adalimumab and Infliximab in Human Plasma Using a Target-Based Sample Purification and Liquid Chromatography-Tandem Mass Spectrometry.
El Amrani M; Bosman SM; Egas AC; Hack CE; Huitema ADR; van Maarseveen EM
Ther Drug Monit; 2019 Oct; 41(5):640-647. PubMed ID: 31584927
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits.
Truffot A; Jourdil JF; Seitz-Polski B; Malvezzi P; Brglez V; Stanke-Labesque F; Gautier-Veyret E
Clin Biochem; 2021 Jan; 87():60-66. PubMed ID: 33096054
[TBL] [Abstract][Full Text] [Related]
6. Verification between Original and Biosimilar Therapeutic Antibody Infliximab Using nSMOL Coupled LC-MS Bioanalysis in Human Serum.
Iwamoto N; Yokoyama K; Takanashi M; Yonezawa A; Matsubara K; Shimada T
Curr Pharm Biotechnol; 2018; 19(6):495-505. PubMed ID: 29968534
[TBL] [Abstract][Full Text] [Related]
7. Quantification of infliximab and adalimumab in human plasma by a liquid chromatography tandem mass spectrometry kit and comparison with two ELISA methods.
Tron C; Lemaitre F; Bros P; Goulvestre C; Franck B; Mouton N; Bagnos S; Coriat R; Khoudour N; Lebert D; Blanchet B
Bioanalysis; 2022 Jun; 14(11):831-844. PubMed ID: 35735172
[No Abstract] [Full Text] [Related]
8. Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC-MS/MS.
Faria M; Halquist MS; Yuan M; Mylott W; Jenkins RG; Karnes HT
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():156-68. PubMed ID: 26279007
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic drug monitoring of infliximab: performance evaluation of three commercial ELISA kits.
Schmitz EM; van de Kerkhof D; Hamann D; van Dongen JL; Kuijper PH; Brunsveld L; Scharnhorst V; Broeren MA
Clin Chem Lab Med; 2016 Jul; 54(7):1211-9. PubMed ID: 26587745
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Infliximab and Anti-infliximab LISA-TRACKER Immunoassays for the Therapeutic Drug Monitoring of SB2 Infliximab Biosimilar.
Jentzer A; Berger AE; Labetoulle R; Haccourt A; Roblin X; Paul S
Ther Drug Monit; 2018 Dec; 40(6):749-753. PubMed ID: 30439790
[TBL] [Abstract][Full Text] [Related]
11. Accurate analytical method for human plasma glucagon levels using liquid chromatography-high resolution mass spectrometry: comparison with commercially available immunoassays.
Miyachi A; Kobayashi M; Mieno E; Goto M; Furusawa K; Inagaki T; Kitamura T
Anal Bioanal Chem; 2017 Oct; 409(25):5911-5918. PubMed ID: 28801845
[TBL] [Abstract][Full Text] [Related]
12. Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry.
Heudi O; Barteau S; Zimmer D; Schmidt J; Bill K; Lehmann N; Bauer C; Kretz O
Anal Chem; 2008 Jun; 80(11):4200-7. PubMed ID: 18465883
[TBL] [Abstract][Full Text] [Related]
13. Plasma PCSK9 measurement by liquid chromatography-Tandem mass spectrometry and comparison with conventional ELISA.
Croyal M; Fall F; Krempf M; Thédrez A; Ouguerram K; Ferchaud-Roucher V; Aguesse A; Billon-Crossouard S; Mata P; Alonso R; Lambert G; Nobécourt E
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():24-29. PubMed ID: 28064066
[TBL] [Abstract][Full Text] [Related]
14. Generation of a Highly Specific Monoclonal Anti-Infliximab Antibody for Harmonization of TNF-Coated Infliximab Assays.
Van Stappen T; Brouwers E; Tops S; Geukens N; Vermeire S; Declerck PJ; Gils A
Ther Drug Monit; 2015 Aug; 37(4):479-85. PubMed ID: 25525757
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Quantum Blue® reader Point-of-Care system versus ELISA technique for therapeutic drug monitoring of Infliximab levels.
Novakovic V; Abdija S; Larsen PB; Fenger M; Gredal L; Jacobsen KK
Clin Biochem; 2019 Dec; 74():73-75. PubMed ID: 31669514
[TBL] [Abstract][Full Text] [Related]
16. Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma.
Millet A; Khoudour N; Lebert D; Machon C; Terrier B; Blanchet B; Guitton J
Molecules; 2021 Mar; 26(5):. PubMed ID: 33806585
[TBL] [Abstract][Full Text] [Related]
17. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
de Dios K; Manibusan A; Marsden R; Pinkstaff J
J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Infliximab-Treated inflammatory bowel disease patients undergoing therapeutic drug monitoring with two different assays.
Al-Bawardy B; Jenkins SM; Snyder MR; Frinack JL; Ladwig PM; Loftus EV; Willrich MAV
Clin Biochem; 2023 Sep; 119():110618. PubMed ID: 37507083
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous measurement of amiodarone and desethylamiodarone in human plasma and serum by stable isotope dilution liquid chromatography-tandem mass spectrometry assay.
Kuhn J; Götting C; Kleesiek K
J Pharm Biomed Anal; 2010 Jan; 51(1):210-6. PubMed ID: 19720490
[TBL] [Abstract][Full Text] [Related]
20. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
Li W; Lin H; Fu Y; Flarakos J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
